Edward M. Alderman

1.7k total citations · 1 hit paper
11 papers, 1.4k citations indexed

About

Edward M. Alderman is a scholar working on Molecular Biology, Surgery and Rheumatology. According to data from OpenAlex, Edward M. Alderman has authored 11 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Rheumatology. Recurrent topics in Edward M. Alderman's work include Enzyme function and inhibition (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Edward M. Alderman is often cited by papers focused on Enzyme function and inhibition (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Edward M. Alderman collaborates with scholars based in United States and Japan. Edward M. Alderman's co-authors include Roy R. Lobb, James W. Fett, Bert L. Vallée, Daniël J. Strydom, J. L. Bethune, James Riordan, Vicki Rosen, Andrew G. Huvos, Joseph M. Lane and Pilar Garin‐Chesa and has published in prestigious journals such as Biochemistry, Cancer and Analytical Biochemistry.

In The Last Decade

Edward M. Alderman

11 papers receiving 1.4k citations

Hit Papers

Isolation and characterization of angiogenin, an angiogen... 1985 2026 1998 2012 1985 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward M. Alderman United States 7 1.0k 256 190 160 141 11 1.4k
Elena Tanghetti Italy 16 810 0.8× 193 0.8× 287 1.5× 298 1.9× 233 1.7× 23 1.3k
Ning Guo United States 12 632 0.6× 282 1.1× 120 0.6× 159 1.0× 108 0.8× 17 904
Jørgen K. Larsen Denmark 20 430 0.4× 288 1.1× 284 1.5× 115 0.7× 290 2.1× 57 1.2k
Daria Leali Italy 21 831 0.8× 219 0.9× 349 1.8× 82 0.5× 153 1.1× 28 1.4k
L Weir United States 12 1.2k 1.2× 175 0.7× 374 2.0× 227 1.4× 184 1.3× 14 2.0k
Stephen N. Mueller United States 20 927 0.9× 203 0.8× 264 1.4× 284 1.8× 181 1.3× 28 1.9k
Joanna Anders United States 9 559 0.5× 230 0.9× 156 0.8× 190 1.2× 218 1.5× 12 1.2k
Dvorak Hf United States 16 511 0.5× 162 0.6× 319 1.7× 145 0.9× 153 1.1× 26 1.1k
E. Kenneth Parkinson United Kingdom 22 796 0.8× 196 0.8× 125 0.7× 109 0.7× 431 3.1× 37 1.4k
Justin Sturge United Kingdom 21 745 0.7× 316 1.2× 156 0.8× 213 1.3× 360 2.6× 31 1.4k

Countries citing papers authored by Edward M. Alderman

Since Specialization
Citations

This map shows the geographic impact of Edward M. Alderman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward M. Alderman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward M. Alderman more than expected).

Fields of papers citing papers by Edward M. Alderman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward M. Alderman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward M. Alderman. The network helps show where Edward M. Alderman may publish in the future.

Co-authorship network of co-authors of Edward M. Alderman

This figure shows the co-authorship network connecting the top 25 collaborators of Edward M. Alderman. A scholar is included among the top collaborators of Edward M. Alderman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward M. Alderman. Edward M. Alderman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Miller, Michael, et al.. (2013). Measurement of downstream kinase activity modulation as indicator of epidermal growth factor receptor inhibitor efficacy. Analytical Biochemistry. 448. 65–67. 1 indexed citations
3.
Alderman, Edward M., et al.. (2013). Competitive, immunometric assay for fusion protein quantification: Protein production prioritization. Analytical Biochemistry. 446. 1–8. 1 indexed citations
4.
Yoshikawa, Hideki, Kunio Takaoka, Edward M. Alderman, et al.. (1994). Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody. Cancer. 73(1). 85–91. 65 indexed citations
5.
Yoshikawa, Hideki, Joseph M. Lane, Kunio Takaoka, et al.. (1994). Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas. Cancer. 74(3). 842–847. 64 indexed citations
6.
Fett, James W., Daniël J. Strydom, Roy R. Lobb, et al.. (1985). Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry. 24(20). 5480–5486. 773 indexed citations breakdown →
7.
Lobb, Roy R., Marc E. Key, Edward M. Alderman, & James W. Fett. (1985). Partial purification and characterization of a vascular permeability factor secreted by a human colon adenocarcinoma cell line. International Journal of Cancer. 36(4). 473–478. 30 indexed citations
8.
Strydom, Daniël J., James W. Fett, Roy R. Lobb, et al.. (1985). Amino acid sequence of human tumor derived angiogenin. Biochemistry. 24(20). 5486–5494. 290 indexed citations
9.
Fett, James W., Daniël J. Strydom, Roy R. Lobb, Edward M. Alderman, & Bert L. Vallée. (1985). Lysozyme: a major secretory product of a human colon carcinoma cell line. Biochemistry. 24(4). 965–975. 32 indexed citations
10.
Alderman, Edward M., Roy R. Lobb, James W. Fett, et al.. (1985). Angiogenic activity of human tumor plasma membrane components. Biochemistry. 24(27). 7866–7871. 5 indexed citations
11.
Lobb, Roy R., Edward M. Alderman, & James W. Fett. (1985). Induction of angiogenesis by bovine brain derived class 1 heparin-binding growth factor. Biochemistry. 24(19). 4969–4973. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026